The European Court of Human Rights (ECHR) confirmed that it will examine the appeal of double Olympic champion Caster Semenya against regulations requiring female athletes with high testosterone levels to take medication on the 15th of next month.
The 33-year-old South African athlete won a long legal battle last July against Switzerland at the ECHR, which ruled that she was the victim of discrimination from the Lausanne-based Court of Arbitration for Sport.
But Swiss authorities, supported by World Athletics, have taken the matter to the ECHR’s Grand Chamber, with hearings now set to start in three weeks.
Semenya, who is classed as having “differences in sexual development (DSD)” but has always been legally identified as female, has refused to take drugs to reduce her testosterone levels since World Athletics introduced the original rules in 2018.
As a result, she has been barred from competing at her preferred 800m distance and was forced to make an unsuccessful move up to 5 000m.
Semenya has previously described the July verdict as a glimpse of home for sportswomen in the face of adversity. Written by Ray Mabawa
Written by: Lindiwe Mabena
3:00 am - 5:00 am
5:00 am - 9:00 am
9:00 am - 12:00 pm
12:00 pm - 3:00 pm
3:00 pm - 6:00 pm
COPYRIGHT 2023